Comparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial

Authors

  • Fataneh Hashem-Dabaghian 1- Research Institute for Islamic and Complementary Medicine, School of Persian medicine, Iran University of Medical Sciences, Tehran, Iran. 2- School of Persian medicine, Iran University of Medical Sciences, Tehran, Iran
  • Fatemeh Yousefi 1- Research Institute for Islamic and Complementary Medicine, School of Persian medicine, Iran University of Medical Sciences, Tehran, Iran. 2- School of Persian medicine, Iran University of Medical Sciences, Tehran, Iran
  • Ismail Nazem Department of Persian medicine, School of Persian medicine, Tehran University of medical Science, Tehran, Iran.
  • Jaleh Aliasl Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, Iran
  • Maryam Kashanian Department of Obstetrics and Gynecology, Iran University of Medical Science, Tehran, Iran.
  • Omod sadeghpour 1- Research Institute for Islamic and Complementary Medicine, School of Persian medicine, Iran University of Medical Sciences, Tehran, Iran. 2- School of Persian medicine, Iran University of Medical Sciences, Tehran, Iran
  • sodabeh bioos Department of Persian medicine, School of Persian medicine, Tehran University of medical Science, Tehran, Iran.
Abstract:

Objective: Golnar product is a poly herbal formulation advised by Persian medicine to control heavy menstrual bleeding (HMB). This study was conducted to compare the efficacy of this product with placebo in patients with HMB. Materials and Methods: In this double-blind randomized clinical trial, 100 women with HMB were randomly assigned into two groups. The patients in the Golnar group (n=50) took Golnar capsules 500 mg three times a day for the first 7 days of menstrual cycle for three cycles. The placebo group (n=50), took placebo capsules in the same manner. The duration and volume of bleeding (using Pictorial Blood Loss Assessment Chart: PBAC), quality of life (using Menorrhagia Questionnaire: MQ), and hemoglobin level (Hb) were measured 3 months after initiation of the intervention. Results: Eighty-two patients (43 in the Golnar and 39 in the placebo groups) completed the 3-month intervention period. In the Golnar group, PBAC score decreased from 201.62 (144.11) to 109.44 (69.57) (p<0.001) and MQ score improved significantly from 0.58 (0.27) to 0.39 (0.31) (p<0.001), while changes in placebo group were not significant. Hb increased in the Golnar group from 12.78±0.98 to 12.97±0.95 mg/dl (p=0.048) and decreased in the placebo group from 12.94±1.08 to 12.44±1.01mg/dl (p<0.001). No significant adverse effects were found in the Golnar group. Conclusion: The Golnar product can be considered an effective intervention for patients with HMB. Assessment of side-effects is suggested to be performed in a larger sample. In addition, a comparison between the Golnar product and nonsteroidal anti-inflammatory drugs could be valuable.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Anti-hemorrhagic activity of Punicagranatum L. flower (Persian Golnar) against heavy menstrual bleeding of endometrial origin: a double-blind, randomized controlled trial

  Background: Heavy menstrual bleeding of endometrial origin (HMB) is a major healthcare problem in premenopausal women and affects several aspects of women’s health and quality of life (QoL). The aim of this study was to compare the efficacy of Persian Golnar (PG) and tranexamic acid (TA) on heavy menstrual bleeding of endometrial origin (HMB) and patients’ QoL.   Methods : A double-blind rand...

full text

Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial

Background and objectives: Aseprugo procumbens is used as antianxety and depression in Iranian traditional medicine; however no clinical trial has been performed about these properties. The aim of this study was to evaluate the antidepressant efficacy and safety of hydroalcoholic extract of A. procumbens. Methods: In this double blind study, 3...

full text

Assessment of an anti-cellulite cream: A randomized, double-blind, placebo controlled, right-left comparison, clinical trial

Background: Cellulite is a common disease whose exact mechanism is unknown. This study was aimed to assess the safety and efficacy of an anti-cellulite preparation compared with placebo in a randomized double-blind, right-left comparison clinical trial.Methods: Twelve healthy women aged 22 to 58 years with mild to moderate cellulite on their thighs and buttocks participated in this trial. The a...

full text

Anti-hemorrhagic activity of Punica granatum L. flower (Persian Golnar) against heavy menstrual bleeding of endometrial origin: a double-blind, randomized controlled trial

BACKGROUND Heavy menstrual bleeding of endometrial origin (HMB) is a major healthcare problem in premenopausal women and affects several aspects of women's health and quality of life (QoL). The aim of this study was to compare the efficacy of Persian Golnar (PG) and tranexamic acid (TA) on heavy menstrual bleeding of endometrial origin (HMB) and patients' QoL. METHODS A double-blind randomize...

full text

Comparing the Effect of Memantine and Placebo on Clinical Outcome of Intracranial Hemorrhage: A Randomized Double Blind Clinical Trial

Background: Intracerebral Hemorrhage (ICH) is a stroke type which resulted in disability. Memantine have been supposed to have the effect on the functional status in patients with ICH. Objectives: Comparing the effect of memantine with placebo on the clinical outcome of ICH. Materials and Methods: This double-blind clinical trial was conducted in an academic hospital in northern Iran on patient...

full text

Efficacy and safety of bupropion in quality of life of cancer patients, a randomized double blind placebo controlled clinical trial

Background and purpose: Decreasing the quality of life in cancer patients is an essential factor that influences their lives during the process of treatment and after that. A lot of studies have been done to evaluate the efficacy of medical agents on quality of life. In this study, we evaluate the efficacy of Bupropion as an antidepressant agent in quality of life of cancer patients. Materials...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue 5

pages  523- 532

publication date 2020-09-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023